Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 287

1.

RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.

Yan HHN, Lai JCW, Ho SL, Leung WK, Law WL, Lee JFY, Chan AKW, Tsui WY, Chan ASY, Lee BCH, Yue SSK, Man AHY, Clevers H, Yuen ST, Leung SY.

Gut. 2017 Sep;66(9):1645-1656. doi: 10.1136/gutjnl-2016-311849. Epub 2016 Jun 21.

PMID:
27329244
2.

Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.

Kim KM, Lee EJ, Ha S, Kang SY, Jang KT, Park CK, Kim JY, Kim YH, Chang DK, Odze RD.

Am J Surg Pathol. 2011 Sep;35(9):1274-86. doi: 10.1097/PAS.0b013e318224cd2e.

PMID:
21836485
3.
4.

RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.

Fennell LJ, Clendenning M, McKeone DM, Jamieson SH, Balachandran S, Borowsky J, Liu J, Kawamata F, Bond CE, Rosty C, Burge ME, Buchanan DD, Leggett BA, Whitehall VLJ.

Fam Cancer. 2018 Jan;17(1):63-69. doi: 10.1007/s10689-017-0003-0.

5.

A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome.

Boparai KS, Dekker E, Polak MM, Musler AR, van Eeden S, van Noesel CJ.

Am J Pathol. 2011 Jun;178(6):2700-7. doi: 10.1016/j.ajpath.2011.02.023.

6.

Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.

Rosty C, Buchanan DD, Walsh MD, Pearson SA, Pavluk E, Walters RJ, Clendenning M, Spring KJ, Jenkins MA, Win AK, Hopper JL, Sweet K, Frankel WL, Aronson M, Gallinger S, Goldblatt J, Woodall S, Arnold J, Walker NI, Jass JR, Parry S, Young JP.

Am J Surg Pathol. 2012 Jun;36(6):876-82. doi: 10.1097/PAS.0b013e31824e133f.

7.
8.

BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum.

Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR, Leggett BA.

Gut. 2004 Aug;53(8):1137-44.

9.

KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.

Yamane LS, Scapulatempo-Neto C, Alvarenga L, Oliveira CZ, Berardinelli GN, Almodova E, Cunha TR, Fava G, Colaiacovo W, Melani A, Fregnani JH, Reis RM, Guimarães DP.

Oncol Rep. 2014 Oct;32(4):1419-26. doi: 10.3892/or.2014.3338. Epub 2014 Jul 18.

PMID:
25050586
10.

RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.

Bond CE, McKeone DM, Kalimutho M, Bettington ML, Pearson SA, Dumenil TD, Wockner LF, Burge M, Leggett BA, Whitehall VL.

Oncotarget. 2016 Oct 25;7(43):70589-70600. doi: 10.18632/oncotarget.12130.

11.

The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.

Renaud F, Mariette C, Vincent A, Wacrenier A, Maunoury V, Leclerc J, Coppin L, Crépin M, Van Seuningen I, Leteurtre E, Buisine MP.

Int J Cancer. 2016 Mar 15;138(6):1472-81. doi: 10.1002/ijc.29891. Epub 2015 Oct 30.

12.

Externalization of saw-tooth architecture in small serrated polyps implies the presence of methylation of IGFBP7.

Kaji E, Uraoka T, Kato J, Hiraoka S, Suzuki H, Akita M, Saito S, Tanaka T, Ohara N, Yamamoto K.

Dig Dis Sci. 2012 May;57(5):1261-70. doi: 10.1007/s10620-011-2008-0. Epub 2011 Dec 16.

PMID:
22173745
13.

BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?

Velho S, Moutinho C, Cirnes L, Albuquerque C, Hamelin R, Schmitt F, Carneiro F, Oliveira C, Seruca R.

BMC Cancer. 2008 Sep 9;8:255. doi: 10.1186/1471-2407-8-255.

14.

Colorectal serrated adenocarcinoma.

Mäkinen MJ.

Histopathology. 2007 Jan;50(1):131-50. Review.

PMID:
17204027
15.

Prevalence and molecular characterisation of the sessile serrated adenoma in a subset of the Chinese population.

Qiu Y, Fu X, Zhang W, Xu Y, Xiao L, Chen X, Shi L, Zhou X, Xia G, Peng Y, Deng M.

J Clin Pathol. 2014 Jun;67(6):491-8. doi: 10.1136/jclinpath-2013-202092. Epub 2014 Feb 25.

PMID:
24570042
16.

Proximal colon cancers and the serrated pathway: a systematic analysis of precursor histology and BRAF mutation status.

Patil DT, Shadrach BL, Rybicki LA, Leach BH, Pai RK.

Mod Pathol. 2012 Oct;25(10):1423-31. doi: 10.1038/modpathol.2012.98. Epub 2012 Jun 8.

17.

Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E.

Mesteri I, Bayer G, Meyer J, Capper D, Schoppmann SF, von Deimling A, Birner P.

Mod Pathol. 2014 Jan;27(1):135-44. doi: 10.1038/modpathol.2013.126. Epub 2013 Jul 26.

18.

MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.

Farchoukh L, Kuan SF, Dudley B, Brand R, Nikiforova M, Pai RK.

Am J Surg Pathol. 2016 Oct;40(10):1390-9. doi: 10.1097/PAS.0000000000000695.

PMID:
27438990
19.

Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.

Murakami T, Akazawa Y, Yatagai N, Hiromoto T, Sasahara N, Saito T, Sakamoto N, Nagahara A, Yao T.

Diagn Pathol. 2018 Nov 20;13(1):88. doi: 10.1186/s13000-018-0771-3.

20.

Frequent PTPRK-RSPO3 fusions and RNF43 mutations in colorectal traditional serrated adenoma.

Sekine S, Yamashita S, Tanabe T, Hashimoto T, Yoshida H, Taniguchi H, Kojima M, Shinmura K, Saito Y, Hiraoka N, Ushijima T, Ochiai A.

J Pathol. 2016 Jun;239(2):133-8. doi: 10.1002/path.4709. Epub 2016 Apr 9.

PMID:
26924569

Supplemental Content

Support Center